Axavive has introduced a plant-based skin support supplement featuring Astragaloside IV, a compound derived from Astragalus membranaceus, aimed at promoting collagen wellness, antioxidant defense, and skin hydration. The formula includes six botanical ingredients designed to support skin structure, elasticity, and cellular repair pathways. While ingredient-level research supports the potential benefits of Astragaloside IV, no clinical trials on the finished product exist, and the supplement is not FDA-approved to treat or prevent aging. Axavive is manufactured in the USA under GMP standards, sold exclusively online starting at $158, and comes with a 90-day money-back guarantee for customer assurance.
Perplexity AI CEO Aravind Srinivas shared lessons from Nvidia's Jensen Huang and Tesla's Elon Musk, highlighting Huang's mindset of running Nvidia as if it could fail within 30 days despite its $5 trillion valuation and advanced technology. Srinivas ...
Meta Platforms introduced an AI-powered feature called "AI Mode" within Facebook Search, which uses Meta's AI model Muse Spark to provide answers from public content rather than traditional search results. This innovation could generate over $10 bill...
Cuprina Holdings shares surged 111.84% intraday following FDA 510(k) clearance for its MEDIFLY Maggots wound care product, the first maggot debridement therapy using Lucilia cuprina species approved in the U.S. The product treats non-healing necrotic...
Cortea secured €12 million in funding led by Dawn Capital to develop AI-powered Audit Quality Agents that review audit reports and financial statements, identifying errors and inconsistencies before sign-off. These tools help audit firms improve qual...
Cortea secured €12 million in seed funding led by Dawn Capital to develop AI tools that enhance audit quality without compromising accuracy. Their Audit Quality Agents review audit reports and financial statements to detect inconsistencies and errors...
